The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form - Global" category.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Our experts answering your questions: Solid-state characterization and crystallization process development
Article
In API development, solid-state characterization analyzes the physical and chemical properties of the API in its solid form, a crucial step in formulation development. Meanwhile, crystallization process development ensures the creation of reliable crystalline structures, which is essential for safe and effective oral solid dose products.
Our new article features a Q&A with Thermo Fisher Scientific’s subject matter experts on the importance of solid-state characterization and crystallization process development, including why these processes should happen early on in drug development. It also explores how an end-to-end CDMO partner can help prevent delays and additional costs.
